Fig. 3

Association of immune cell subsets with efficacy of ICI plus chemotherapy. Comparisons of immune cell subsets proportions in different subgroups: Indicators comparison between patients pre- and after-treatment (A). Pre-treat indicators comparison between patients in CB and NB groups (B). On-treatment indicators comparison between patients in CB and NB groups (C). Dynamic changes of indicators comparison between patients in CB and NB groups (D). Abbreviations: CB, clinical benefits, NB, non-benefit. *P < 0.1